Sirtris Pharmaceuticals, Inc.Cambridge, MA United States
Company Description
Sirtris can help keep you healthy in your golden years. The biopharmaceutical company focuses on developing drugs for treating ailments of aging. Its primary candidate is designed to treat Type 2 Diabetes, which is associated with obesity, by providing health benefits similar to calorie restriction without a change in diet. Other candidates include drugs to treat cancer, cardiovascular, and other diseases often linked to obesity. Sirtris owns or licenses several patent applications for sirtuins, a class of enzymes believed to be associated with the aging process. The activation of sirtuins helps reduce weight gain and improve glucose levels and insulin sensitivity. Sirtris is a subsidiary of
| 200 Technology Sq. | Phone: 617-252-6920 | |
| Cambridge, MA 02139 | Fax: 617-252-6924 | 
Map This Company |
| United States |
Try a Full Premium Subscription
Access over 85 million companies
Call (866) 443-3939 or
Prepare for your Sales call
Try a Small Business Subscription
Starting $89 per month
Sirtris Pharmaceuticals, Inc. Rankings
Executives
| 27 executives listed for Sirtris Pharmaceuticals, Inc.'s Cambridge, MA location. | ||
| CEO | Christoph Westphal | |
|---|---|---|
| COO | Garen Bohlin | |
| SVP Development | Peter Elliott | |
Financials
| Company Type | SubsidiarySingle Location |
|---|---|
| Fiscal Year-End | December |
| Employees | 57 |
DNBiLeverage D&B's credit assessment tools to positively impact
your business. Get the scoop on Sirtris Pharmaceuticals, Inc. now.
- Reduce risk.
- Drive greater profitability.
- Increase cash flow.
